Events

2nd European Quantum Technologies Conference
NOV
Mon
29
NOV
Tue
30
DEC
Wed
01
DEC
Thu
02
DEC
Fri
03

This was 4 years ago

Location

The Convention Centre



Dublin



Ireland 


Programmes
FET ICT

 

Following discussions between the Irish Centre for High-End Computing (ICHEC), EU Quantum Flagship and European Commission, the second European Quantum Technologies Conference (EQTC) which had been scheduled to take place in November 2020 is now postponed to 29th November – 3rd December 2021 at Dublin, Ireland.

Further details with updated information will be published at the event website www.eqtc.org. The organisers at Irish Centre for High-End Computing (ICHEC) can be reached at info@eqtc.org.

More information

EQT Conference website

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.